Cellular and Humoral Immune Response to Primary and Secondary Immunization With Subvirion H5N1 Vaccines

NCT01086566 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

95

Enrollment

NIH

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Influenza Virus Vaccine, Monovalent A/H5N1 A/Indonesia/05/2005

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)